Incyte Corporation

This stock has a reasonable momentum. Incyte Corporation is not very popular among insiders. Incyte Corporation is a mediocre stock to choose.

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commerc...

News

Savant Capital LLC Lowers Position in Incyte Co. (NASDAQ:INCY)

Zolmax Savant Capital LLC cut its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 64.3% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange...\n more…

National Bank of Canada FI Raises Stock Holdings in Incyte Co. (NASDAQ:INCY)

Ticker Report National Bank of Canada FI lifted its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 6.9% in the 2nd quarter, Holdings Channel reports. The firm owned 43,919 shares of the...\n more…

TD Asset Management Inc Has $5.23 Million Stake in Incyte Co. (NASDAQ:INCY)

Ticker Report TD Asset Management Inc decreased its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 27.7% during the second quarter, according to the company in its most recent filing with the SEC...\n more…

Incyte Co. (NASDAQ:INCY) Shares Sold by Arizona State Retirement System

Ticker Report Arizona State Retirement System reduced its position in Incyte Co. (NASDAQ:INCY - Free Report) by 17.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...\n more…

Incyte (NASDAQ:INCY) Receives "Neutral" Rating from Cantor Fitzgerald

Ticker Report Cantor Fitzgerald restated their neutral rating on shares of Incyte (NASDAQ:INCY - Free Report) in a research report report published on Monday morning, Benzinga reports. Other equities research...\n more…

William Blair Reiterates "Outperform" Rating for Incyte (NASDAQ:INCY)

Zolmax William Blair restated their outperform rating on shares of Incyte (NASDAQ:INCY - Free Report) in a report issued on Monday morning, RTT News reports.\nINCY has been the topic of a number of other...\n more…